产品
编 号:F001092
分子式:C46H56ClF2N6O8PS
分子量:957.46
产品类型
规格
价格
是否有货
结构图
联系客服
产品详情
生物活性:
GS-9256 is a selective HCV NS3 protease inhibitor. GS-9256 has good pharmacokinetic properties and antiviral activity.

体内研究:
GS-9256 (1 mg/kg, i.v., 30 min) is highly bioavailable in mice (near 100%) and moderately bioavailable in rats (14%), dogs (21%) and monkeys (14%). The elimination half-life is approximately 2 hours in mice, 0.6 hours in rats, 5 hours in dogs, and 4 hours in monkeys. The pharmacokinetic parameters of GS-9256(IV, 2 mg/kg mouse and 1 mg/kg rat, dog, monkey; Oral, 50 mg/kg mouse, 5 mg/kg rat and monkey, 4 mg/kg dog) -ParametersCD-1 mouseSprague Dawley ratBeagle dogCynomolgus monkeyIntravenousCL(L/h/kg)2.01.260.040.33

Vss (L/kg)2.30.160.090.27

t1/2(h)2.350.614.883.95

MRT(h)1.150.132.110.82

OralTmax(h)3.000.672.002.67

Cmax(nM)111162654369604

t1/2(h)1.310.534.224.42

AUC0-∞(nM*h)58959445210432304

F(%)Complete13.92114

体外研究:
GS-9256 (0.002-0.183 μM) has a mean EC50 value of 20 nM in GT1b huh-luc cells with a replicon encoding luciferase. GS-9256 (3 μM) retains wild-type activity against all NS5B and NS5A inhibitor-resistant mutations tested and is metabolically stable in microsomes and hepatocytes including rodents, dogs and humans.
产品资料